Twenty years ago, Ernst Sorkin demonstrated that 7s
antibodies could adhere to the surface membranes of macrophages and confer upon the cells the capacity to take up antigen (Sorkin, 1963) . Early progress in the investigation of these antibodies was hampered by the erroneous assumption that the cytophilic activity was restricted to a minor immunoglobulin subclass and a decade was to pass before a specific receptor with measurable affinity for homologous monomeric IgG was characterized on rabbit macrophages (Arend & Mannik, 1973) . Since then, the study of Fc receptors on phagocytes from various species has progressed rapidly to the point where we now possess considerable knowledge of their specificity, structure and function. The purpose of this presentation is to review some of the information we have acquired over these last 10 years.
The extent of characterization of the primary interaction between monomeric immunoglobulins and phagocyte Fc receptors varies greatly from species to species. The most rigorous, performed on mouse macrophages, has involved independent measurements of forward-and reverse-rate and association constants and the isolation and physicochemical characterization of the receptors. These studies have been assisted by the identification of macrophage-like mouse cells lines and by raising a monoclonal antibody against one of the receptors. At the other extreme, evidence of cytophilic activity is limited to the demonstration that monomeric immunoglobulins can inhibit phagocyte binding of antigen-antibody complexes. The variability in available data makes detailed interspecies comparisons difficult. However, certain features are immediately apparent. The first is the diversity in receptor affinity and expression that exists between species. The association constants for monomeric IgG vary over a 200-fold range in the species examined and appear to be inversely related to the number of receptors expressed per cell (Table 1) . It is presumed that the inverse relationship is compensatory in biological terms, though the precise implications of this relationship have yet to be established. One consequence which has been recognized is that in species with high-affinity receptors for IgG, the attachment of IgG-coated targets is blocked more effectively by low concentrations of monomeric IgG than in species where the receptor affinity is low (Alexander et al., 1978) . Fc-receptor affinity is thus likely to be a critical Abbreviation used: Ig, immunoglobulin.
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factor in determining phagocyte dependence on ligands other than IgG (e.g. C3b, mannosyl groups) for target recognition in the blood stream, where the concentration of IgG is high.
A second feature to emerge is that in many species the macrophages express a variety of receptors with specificity for different immunoglobulin classes and subclasses. This situation is particularly well defined in the mouse where distinct receptors are involved in binding murine IgG2a (FcR I), IgG2b/IgGl (FcR 11), IgG3 and IgE ( 1983) , in antigenic properties (Unkeless, 1979) , in sensitivity to proteases (Unkeless & Eisen, 1975) and in their physicochemical characteristics (Mellmann & Unkeless, 1980; Lane & Cooper, 1982) . The biological implications of this diversity are still unresolved, although it has been proposed that the different receptors may trigger different activities in the phagocytes by transmitting diverse signals following ligand attachment (Silverstein et al., 1977) . The proposal is supported by a report that the murine IgG2b receptor (FcR 11) possesses an inducible phospholipase A2 activity, whereas the IgG2a receptor (FcR I) does not (Suzuki et al., 1982) .
Neutrophil receptors for immunoglobulin remain poorly characterized (Table l) , a consequence of either their paucity on the neutrophil surface, as is the case in guinea pigs (Coupland & Leslie, 1983) , or their low affinity, as reported in humans (Kurlander & Bakter, 1982) . The latter observation suggests that the human neutrophil receptor may differ structurally from its macrophage counterpart, a view supported by the finding that a monoclonal antibody raised against the neutrophil receptor fails to react with the receptor on freshly explanted monocytes (Fleit et al., 1982) .
Little is yet known about the structure of phagocyte Fc receptors other than that they are glycoproteins of between 50 and 70 kilodaltons in size (Table 1 ). The location of the binding site on the immunoglobulin molecules has been a source of controversy, with conflicting reports of binding activity associated with the Cy2 and Cy3 domains of IgG and the Cc3 and/or Cc4 domains of IgE (reviewed by Leslie & Alexander, 1979) . Much of the confusion may be associated with the use of heterologous assay systems (e.g. human IgG with guinea-pig macrophage) in which immunoglobulin binding may occur by a totally independent (i.e. non-Fc-receptor-mediated) mechanism (Leslie & Neimetz, 1979) or by cross-reaction with the heterologous phagocytes (1978) .
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Fc receptor via a site that is distinct from the site involved in recognizing the homologous receptor (Ratcliffe & Stanworth, 1983 et al., 1976) . A consistent observation from numerous investigations of phagocyte Fc receptor activity is that oligomers of cytophilic immunoglobulin are bound more effectively than the monomer. The phenomenon has been observed using heataggregated and random, covalently cross-linked immunoglobulins as well as immune Complexes formed with soluble antigens and antibodies which have been covalently crosslinked via their Fab regions with bivalent affinity-labelling reagents. For mouse and guinea-pig phagocytes, the enhancement has been unequivocally identified with an increase in avidity of the oligomers for the receptors Segal & Hurwitz, 1977) , whereas with human monocytes there are conflicting reports of an avidity increase (Kurlander & Batker, 1982) and of additional binding to a population of low-affinity receptors which are not detectable when monomeric IgG is used as the binding probe (Carter et al., 1982; Rasmussen et al., 1983) .
The mechanism of avidity change has been investigated using both soluble immune complexes of defined size Leslie, 1980) and affinity crossed-linked antibody oligomers (Segal & Hurwitz, 1977; Dower et al., 1981a,b) . With antigen-containing complexes it has been observed that each complex binds with a uniform avidity which increases with complex size (Segal & Hurwitz, 1977; Leslie, 1980~) . Analysis of the binding data in thermodynamic terms has indicated that the enhanced avidity of complexes for phagocyte receptors can be accounted for by simple multivalent attachment of antigen cross-linked antibodies in their native configuration (Segal & Hurwitz, 1977; Leslie, 19804 rather than by antigen-induced conformational changes in the binding domain. More recent studies by Dower er al. (1981~) employing oligomers which are antigen-free, while confirming this conclusion, also indicate that the basis of complex binding may be more complicated. The antigen-free dimer and trimer ligands differ from normal complexes in that their avidity declines with increase in occupancy of the macrophage receptors, reflecting a decrease in the valency of attachment as the availability of vacant receptors drops. A similar phenomenon was observed when hapten-containing oligomers were reacted with the cells in high concentrations of free hapten. Consequently, the uniform binding seen with antigenbinding complexes was attributed to a combination of events in which additional antibody-antigen bridging to form larger, more adherent aggregates compensates for the reduction in valency of binding at high membrane concentrations of complex (Dower et al., 1981~) .
The impetus for additional bridging arises from the massive increase in effective concentration of the complexes that occurs when they attach to the membrane receptors. Using independent approaches, Dower et al. (1981~) and Leslie (1982) have estimated that when binding equilibrium is established at low concentrations ( 10-M) of soluble complexes, the effective concentration of complexes at the cell surface (between 3 x and 1 0 -4~) will be 1O4-1O3-fold greater than the complex concentration in solution. Since the affinity constant of antibody for antigen in the complexes is about IO'M-' (Leslie, 1980~; Dower el al., 1981a) , it follows that attachment of the complexes to the phagocyte membrane under these conditions should drive the antibody-antigen interaction to virtual Vol. 12 completion. Confirmation of the validity of this model is provided by the observation that fluoresceinated soluble complexes rearrange into discrete clusters on the phagocyte surface before ingestion and that microfilaments play no part in cluster formation (Leslie, 1982) .
The capacity of soluble complexes to aggregate at the phagocyte surface is probably an important determinant for the selective clearance of small, non-complement-fixing complexes from the blood stream, where high concentrations of monomer IgG prevail. Monomer IgG competes effectively with complexes for the phagocyte receptors Alexander et al., 1978) and at low temperature, where ingestion is inhibited, IgG virtually abolishes the phagocyte uptake of small (dimeric to tetramic) complexes when present at the concentration (5-10 x 10-5~)foundinnormalserum(Doweretal., 1981~). At 37"C, the equilibrium is disturbed in that complexes which do attach to the phagocytes may be rapidly and irreversibly ingested (Leslie, 19806; Segal et al., 1983a,b) , whereas the binding of monomeric subunits remains essentially reversible. Consequently the monomer may slow considerably the rate at which complexes are taken up and ingested but is unable to block the process completely. Current evidence indicates that soluble complexes do not trigger their own endocytosis but are ingested as membrane-attached ligands in the course of fluid-phase pinocytosis (Leslie, 1980~1, 1982 Segal et al., 19836) . The key factor, therefore, in determining whether or not a sample becomes ingested is the length of time it remains attached to phagocyte receptors (Segal et al., 1983a,6) . Since the residence time is directly related to the multivalency of the complex (Dower et al., 19816) , the self-association of small complexes to form larger ones at the cell membrane should prove a powerful mechanism for increasing the probability of ingestion by prolonging the time of attachment. Experimental evidence in favour of this hypothesis is furnished by the observations that antigencontaining oligomers differ from their antigen-free counterparts in that they dissociate more slowly from the phagocyte surface at 0°C (Dower er al., 1981h), they are ingested by phagocytes in oitro in the presence of lOmg of monomeric IgG/ml (Segal et al., 19836) and they display between 2-and 10-fold faster clearance kinetics in uioo (Plotz et al., 1979) . It remains to be established whether naturally occurring complexes which are relatively homogeneous antigenically, such as the IgG-anti-IgG complexes formed in patients with rheumatoid arthritis, behave in a similar manner.
The human monocyte is often depicted as interacting with human IgG via the Cy3 domain. This localization has been postulated largely on the basis of the ability of pFc' fragment (Cy3 dimer) and other Cy3 fragments to inhibit the interaction of monocytes and IgG. However, the inhibition by pFc' fragment preparations is observed only at concentrations orders of magnitude greater than for the parent IgG and therefore could be attributable to minor contamination by the parent IgG. Using a microassay system to measure binding of 2SI-labelled human IgG to monocytes we find that conventionally prepared pFc' is indeed inhibitory. This conventional preparation, however, reacted with monoclonal antibodies specific for Cy2 and Lchain epitopes indicating that intact IgG (and possibly Fc) was present. Extensive immunoaffinity purification of the pFc' preparation by passage over affinity columns having binding specificity for IgG yielded a product reactive with anti-Cy3 but not anti-Cy2 monoclonal antibodies. In our assay system this pFc' preparation did not significantly inhibit the monocyte-IgG interaction. We therefore conclude that inhibition by conventional pFc' fragment is a result of contamination (< 1%) by parent IgG or Fc.
To further investigate the domain(s) involved in FcR binding we studied the behaviour of Cy2-and Cy3-deleted IgGs as inhibitors of the monocyte-IgG interaction. Protein TIM (Nik Jaafar & Jefferis, 1984) reacts with monoclonal antibodies from an anti-pFc' panel but with none from a panel of non-pFc' anti-Fc antibodies, and probably has a complete Cy2 deletion. Protein SIZ (Nik Jaafar & Jefferis, 1984) reacts with a number of the non-pFc' anti-Fc antibodies and probably has a complete Cy3 deletion. Both proteins were extensively purified by immunoaffinity columns. Neither of the deleted proteins was found to significantly inhibit the monocyte FcR-IgG interaction in Abbreviations used : FcR, Fc receptor; Ig, immunoglobulin. our assay. There are several possible explanations for this. Firstly, Cy2 and Cy3 may both contribute to monocyte binding but neither has an overwhelmingly dominant role. Secondly, Cy2 alone may be involved in monocyte binding but conformational integrity is lost in protein SIZ [Cy2 has been described as a partially 'soft' domain (Deisenhofer, 1981) l. Thirdly, the Cy3 alone may bind monocytes but conformational integrity or site accessibility is lost in TIM. However, the closely paired stable nature of the Cy3 dimer and the large number of anti-pFc' monoclonal antibodies which recognize TIM argue against this explanation.
The effect of the loss of the N-linked carbohydrate chains from Cy2 was investigated using a monoclonal antibody produced by a mouse hybridoma. Monoclonal mouse IgG2a inhibited the binding of labelled human IgG to monocytes as effectively as unlabelled human IgG. When the hybridoma was grown in medium containing tunicamycin, an aglycosylated IgG2a lacking the Cy2 carbohydrate chains was produced. This protein binds Clq and protein A with similar affinity to glycosylated IgG2a (R. J. Leatherbarrow & R. A. Dwek, unpublished work). However, we found at least a 50-fold reduction in monocyte-binding affinity. Since we found the isolated glycopeptide was not inhibitory up to 0.1 ~I M concentration we conclude that the decreased monocyte affinity is due to perturbation of Cy2 domain structure on aglycosylation. This perturbation is not felt at the Cy2/Cy3 interface constituting the protein A-binding site.
The hinge sensitivity of monocyte binding was also investigated. The hinge-deleted IgG 1 Dob protein showed decreased ability to inhibit the monocyte-IgG interaction. The inhibition is so weak that it may result from minor contamination of normal IgG in the Dob preparation. From examination of the crystal structure of Dob (Sarma & Laudin, 1982) it is expected that Cy2 binding sites would be perturbed by hinge-deletion rather than Cy3 binding sites. Indeed, hinge-deletion is not felt at the Cy2/Cy3 interface region since protein A binding to Dob is similar to that for normal IgG (Klein et al., 1981) .
Mild reduction and alkylation of normal human IgG had little or no effect on its inhibitory ability in our binding assay.
